Associated Medical Conditions for Obesity

๐Ÿ“น Explaining this page and it's appropriate use.
The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Overlap Percent Prevalance in Population Matches Bacteria in From Bacteria in To
Allergies 22 % 30% 11 50 104
Alzheimer's disease 22 % 10% 11 50 55
Alzheimer's disease 30 % 10% 15 50 104
Autism 32.7 % 2% 18 110 55
Autism 21.2 % 2% 22 110 104
Ulcerative colitis 27.3 % 0.1% 15 108 55
Ulcerative colitis 26 % 0.1% 27 108 104
Rosacea 13.6 % 5.46% 3 22 104
Schizophrenia 29.1 % 0.75% 16 93 55
Schizophrenia 12.9 % 0.75% 12 93 104
Ankylosing spondylitis 34.5 % 7% 19 520 55
Ankylosing spondylitis 39.4 % 7% 41 520 104
Mood Disorders 16.7 % 29.7% 1 6 55
Mood Disorders 66.7 % 29.7% 4 6 104
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 43.6 % 0.86% 24 134 55
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 19.2 % 0.86% 20 134 104
Psoriasis 21.7 % 3% 10 46 55
Psoriasis 26.1 % 3% 12 46 104
Multiple Sclerosis 27.3 % 0.5% 15 100 55
Multiple Sclerosis 18 % 0.5% 18 100 104
Amyotrophic lateral sclerosis (ALS) Motor Neuron 16.3 % 0.005% 7 43 55
Amyotrophic lateral sclerosis (ALS) Motor Neuron 18.6 % 0.005% 8 43 104
Osteoporosis 18.2 % 9.4% 4 22 55
Osteoporosis 22.7 % 9.4% 5 22 104
neuropsychiatric disorders (PANDAS, PANS) 33.3 % 0.1% 5 15 104
ME/CFS with IBS 15.8 % 2.8% 3 19 55
ME/CFS with IBS 21.1 % 2.8% 4 19 104
ME/CFS without IBS 11.5 % 0.4% 3 26 55
ME/CFS without IBS 11.5 % 0.4% 3 26 104
Multiple system atrophy (MSA) 19 % 0.005% 4 21 55
Metabolic Syndrome 14.3 % 21% 1 7 55
Metabolic Syndrome 57.1 % 21% 4 7 104
Systemic Lupus Erythematosus 20 % 0.15% 11 66 55
Systemic Lupus Erythematosus 28.8 % 0.15% 19 66 104
Liver Cirrhosis 69.1 % 0.27% 38 678 55
Liver Cirrhosis 36.5 % 0.27% 38 678 104
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 20 % 25% 11 76 55
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 23.7 % 25% 18 76 104
Parkinson's Disease 29.1 % 1% 16 90 55
Parkinson's Disease 15.6 % 1% 14 90 104
Insomnia 30 % 30% 3 10 55
Insomnia 40 % 30% 4 10 104
Chronic Kidney Disease 25.7 % 15% 9 35 55
Chronic Kidney Disease 25.7 % 15% 9 35 104
Depression 23.6 % 8% 13 81 55
Depression 21 % 8% 17 81 104
Irritable Bowel Syndrome 10.9 % 15% 6 62 55
Irritable Bowel Syndrome 30.6 % 15% 19 62 104
Chronic Urticaria (Hives) 17.4 % 5% 4 23 55
Chronic Urticaria (Hives) 34.8 % 5% 8 23 104
IgA nephropathy (IgAN) 17.2 % 0.001% 5 29 104
Hyperlipidemia (High Blood Fats) 16 % 33% 4 25 55
Hyperlipidemia (High Blood Fats) 20 % 33% 5 25 104
hypertension (High Blood Pressure 33.3 % 47% 2 6 55
hypertension (High Blood Pressure 16.7 % 47% 1 6 104
hypercholesterolemia (High Cholesterol) 33.3 % 12% 3 9 104
Allergic Rhinitis (Hay Fever) 13.9 % 7.8% 5 36 104
gallstone disease (gsd) 20 % 5% 3 15 55
gallstone disease (gsd) 40 % 5% 6 15 104
Graves' disease 12.5 % 0.5% 1 8 104
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 16.7 % 27.8% 4 24 104
Fibromyalgia 16.2 % 1.12% 6 37 55
Fibromyalgia 18.9 % 1.12% 7 37 104
Functional constipation / chronic idiopathic constipation 24.4 % 14% 10 41 55
Gout 14.3 % 6.8% 3 21 104
Epilepsy 12 % 0.84% 3 25 55
Epilepsy 36 % 0.84% 9 25 104
Cerebral Palsy 41.2 % 0.2% 7 17 55
Cerebral Palsy 23.5 % 0.2% 4 17 104
Inflammatory Bowel Disease 23.6 % 1.3% 13 66 55
Inflammatory Bowel Disease 27.3 % 1.3% 18 66 104
Type 1 Diabetes 13.5 % 0.19% 7 52 55
Type 1 Diabetes 19.2 % 0.19% 10 52 104
cystic fibrosis 28.6 % 0.03% 2 7 104
COVID-19 22.2 % 50% 8 36 104
Carcinoma 54.9 % 1% 28 51 55
Carcinoma 15.7 % 1% 8 51 104
Colorectal Cancer 32.7 % 4.3% 18 296 55
Colorectal Cancer 21.2 % 4.3% 22 296 104
Celiac Disease 21.8 % 1.4% 12 67 55
Celiac Disease 25.4 % 1.4% 17 67 104
Chronic Fatigue Syndrome 14.5 % 3% 8 55 55
Chronic Fatigue Syndrome 10.9 % 3% 6 55 104
Crohn's Disease 76.4 % 0.3% 42 141 55
Crohn's Disease 27.9 % 0.3% 29 141 104
Coronary artery disease 12.5 % 6.7% 2 16 55
Coronary artery disease 25 % 6.7% 4 16 104
Barrett esophagus cancer 12.5 % 7% 2 16 104
Bipolar Disorder 27.3 % 3% 9 33 55
Bipolar Disorder 33.3 % 3% 11 33 104
Asthma 29.6 % 8% 8 27 104
Atherosclerosis 40 % 50% 22 524 55
Atherosclerosis 20.2 % 50% 21 524 104
Acne 52.6 % 47% 10 19 104
Stress / posttraumatic stress disorder 20 % 5.2% 11 56 55
Stress / posttraumatic stress disorder 28.6 % 5.2% 16 56 104
Generalized anxiety disorder 21.4 % 2.7% 3 14 104
Small Intestinal Bacterial Overgrowth (SIBO) 18.8 % 52% 3 16 55
Small Intestinal Bacterial Overgrowth (SIBO) 12.5 % 52% 2 16 104
Brain Trauma 22.7 % 0.367% 5 22 55
Brain Trauma 27.3 % 0.367% 6 22 104
Sjögren syndrome 24.4 % 1.2% 10 41 55
Sjögren syndrome 26.8 % 1.2% 11 41 104
Type 2 Diabetes 78.2 % 10.8% 43 267 55
Type 2 Diabetes 38.5 % 10.8% 40 267 104
ADHD 14.9 % 9.4% 7 47 55
ADHD 31.9 % 9.4% 15 47 104
Hashimoto's thyroiditis 28.6 % 0.35% 4 14 55
Hashimoto's thyroiditis 35.7 % 0.35% 5 14 104

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.